Grants and Contributions:

Back to search

Title:

YOUTH - Preclinical Evaluation of an mRNA-LNP Delivered SMYD3 Peptide Therapeutic in a Small Cell Lung Cancer Model

Agreement Number:

1034846

Agreement Value:

$30,000.00

Agreement Date:

Sep 1, 2025 - Feb 28, 2026

Description:

Pre-clinical proof-of-concept studies to assess therapeutic activity in an mRNA-LNP Delivered SMYD3 Peptide Therapeutic both patient-derived cell lines and a murine xenograft model of SCLC. Conduct in vitro screening (viability, proliferation, and apoptosis assays), and in vivo xenograft monitoring. Collect and analyze experimental data; contribute to technical reports and data summaries for internal review and patent support.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.

Location:

Ottawa, Ontario, CA K1M 2J2

Reference Number:

172-2025-2026-Q2-1034846

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

776475691

Recipient Type:

For-profit organization

Recipient's Operating Name:

NuvoBio

Recipient's Legal Name:

NuvoBio Corporation

Federal Riding Name:

Ottawa--Vanier

Federal Riding Number:

35078

Program:

Industrial Research Assistance Program – Youth Employment Program

Program Purpose:

Coverage:

IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

541710